Dr. Reddy's, Ivax to Appeal Zyprexa Patent Decision
Generic drug makers Dr. Reddy's Laboratories and Ivax have vowed to appeal last week's ruling by an Indiana federal court that upheld Eli Lilly's patent on the blockbuster schizophrenia drug Zyprexa....To view the full article, register now.
Already a subscriber? Click here to view full article